On December 4, 2019, the Board of Aptinyx Inc. appointed Dr. Rachel E. Sherman to serve as a member of the Nominating and Corporate Governance Committee of the Board. Dr. Sherman served at the United States Food and Drug Administration (the FDA) for nearly 30 years until her retirement early in 2019.